1,025
Participants
Start Date
April 16, 2019
Primary Completion Date
January 22, 2024
Study Completion Date
January 22, 2024
The Medical City, Pasig
Royal Women's Hospital, Parkville
Memorial Health University Medical Center, Savannah
Mayo Clinic, Jacksonville
University of South Florida USF Health, OB/Gyn, Tampa
Dr. Sudarshan K. Sharma, Ltd. - Gynecologic Oncology, Hinsdale
Nebraska Methodist Hospital, Omaha
Houston Methodist, Houston
Optimum Clinical Research Group - Southwest Women's Oncology & Health, Albuquerque
University of Southern California, Los Angeles
Palo Alto Medical Foundation, Sunnyvale
Bay Area Gynecology Oncology, San Jose
Hospital Sultan Ismail, Johor Bahru
Hospital Raja Perempuan Zainab II, Kota Bharu
Hospital Ampang, Ampang
Hospital Tengku Ampuan Afzan, Kuantan
Hospital Raja Permaisuri Bainun, Ipoh
Hospital Taiping, Taiping
Hospital Seberang Jaya, Seberang Jaya
Hospital Wanita Dan Kanak-kanak Sabah, Kota Kinabalu
Hospital Umum Sarawak, Kuching
Hospital Miri, Miri
Hospital Sibu, Sibu
Hospital Selayang, Batu Caves
National Kidney and Transplant Institute, Quezon City
Philippine General Hospital, Manila
Venn Biosciences Corporation
INDUSTRY